Mechanism of action
Selective antagonist of neurokinin 1 and 3 receptors in hypothalamus; blocks KNDy (kisspeptin/neurokinin B/dynorphin) neuron signaling that regulates core body temperature and thermoregulatory set point.
First-in-class dual NK1/NK3 receptor antagonist approved for treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause.
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2025 The Doctors Platform. All Right Reserved.